Do not use for diagnosis of Epstein-Barr virus infectious mononucleosis. May aid in the detection and prognosis of nasopharyngeal carcinoma.
- Patient Preparation
- Serum separator tube.
- Specimen Preparation
- Separate serum from cells ASAP or within 2 hours of collection. Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimens plainly as "acute" or "convalescent."
- Storage/Transport Temperature
- Unacceptable Conditions
- Plasma. Urine. Contaminated, grossly hemolyzed, or heat-inactivated specimens.
- After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
|Test Number||Components||Reference Interval|
|0050235||Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgG||Effective February 19, 2013|
17.9 U/mL or less: Not Detected
18.0-21.9 U/mL: Indeterminate. Repeat testing in 10-14 days may be helpful.
22.0 U/mL or greater: Detected
|0051626||Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgA||Effective February 19, 2013|
0.79 U/mL or less: Not Detected
0.80 - 1.20 U/mL: Indeterminate. Repeat testing in 10-14 days may be helpful.
1.21 U/mL or greater: Detected
|Component Test Code*||Component Chart Name||LOINC|
|0050235||EBV Antibody to Viral Capsid Antigen IgG||5157-3|
|0051626||EBV Antibody To Viral Capsid Antigen IgA|
- EBV and VCA Ab
- EBV Antibodies
- EBV VCA- Ab
- Infectious Mononucleosis